Similar articles

• Optimized Prognosis Assessment in ST-Segment-Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score.

  Stiermaier T, Jobs A, de Waha S, Fuernau G, Pöss J, Desch S, Thiele H, Eitel I. Stiermaier T, et al. Circ Cardiovasc Imaging. 2017 Nov;10(11):e006774. doi: 10.1161/CIRCIMAGING.117.006774. Circ Cardiovasc Imaging. 2017. PMID: 29122844
• Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).

  Pu J, Ding S, Ge H, Han Y, Guo J, Lin R, Su X, Zhang H, Chen L, He B; EARLY-MYO Investigators. Pu J, et al. Circulation. 2017 Oct 17;136(16):1462-1473. doi: 10.1161/CIRCULATIONAHA.117.030582. Epub 2017 Aug 27. Circulation. 2017. PMID: 28844990 Clinical Trial.
• Cardiovascular Magnetic Resonance for Risk Stratification in Patients With ST-Segment-Elevation Myocardial Infarction: A Novel Tool to Tailor Therapy or Emperor's New Clothes?

  Lønborg J, Engstrøm T. Lønborg J, et al. Circ Cardiovasc Imaging. 2017 Nov;10(11):e007108. doi: 10.1161/CIRCIMAGING.117.007108. Circ Cardiovasc Imaging. 2017. PMID: 29146588 No abstract available.
• Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?

  Bulluck H, Foin N, Tan JW, Low AF, Sezer M, Hausenloy DJ. Bulluck H, et al. Circ Cardiovasc Interv. 2017 Mar;10(3):e004373. doi: 10.1161/CIRCINTERVENTIONS.116.004373. Circ Cardiovasc Interv. 2017. PMID: 28242607 Review.
• Inflammatory markers in ST-elevation acute myocardial infarction.

  Seropian IM, Sonnino C, Van Tassell BW, Biasucci LM, Abbate A. Seropian IM, et al. Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):382-95. doi: 10.1177/2048872615568965. Epub 2015 Feb 13. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25681486 Review.